Back to search
Deaf Children
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Deaf Children trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Deaf Children trials you may qualify forRegeneron is conducting a study of an investigational new drug called DB-OTO. DB-OTO is a gene therapy that is being developed to treat children who have hearin…
The goal of the BEARS clinical trial is to determine whether using the directional listening training delivered via the BEARS training package for 3-months alon…
Using a single-case multiple baseline across participants design, this study aims to explore the effectiveness of parent-implemented Broad Treatment Speech Reca…
The principal aim of this study is to evaluate the cortical developement of perceptual skills and executive functions over time, in children with cochlear impla…
Introduction Rare complex syndromes Patients with complex genetic syndromes, by definition, have combined medical problems affecting multiple organ systems, and…
This study aims to compare the auditory cortical activity in response to monaural and binaural stimuli, measured by functional Near-Infrared Spectroscopy (fNIRS…
Mutual exclusivity is a word learning constraint in which the learner assumes that a given word refers to only one category of objects. In spoken languages, mut…
Children who are deaf and hard of hearing (DHH) rarely receive behavioral interventions to prevent the long-term costly outcomes of behavior problems. This proj…